Cannabis Bioscience International Holdings Inc
OTC:CBIH
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
C
|
Cannabis Bioscience International Holdings Inc
OTC:CBIH
|
US |
|
P
|
Phoenix Asia Holdings Ltd
NASDAQ:PHOE
|
HK |
|
Bark Inc
NYSE:BARK
|
US |
|
A
|
Administradora Americana de Inversiones SA
SGO:AAISA
|
CL |
Income Statement
Earnings Waterfall
Cannabis Bioscience International Holdings Inc
Income Statement
Cannabis Bioscience International Holdings Inc
| Feb-2009 | May-2009 | Aug-2009 | Nov-2009 | Feb-2010 | May-2010 | Aug-2010 | Nov-2010 | Feb-2011 | May-2011 | Aug-2011 | Nov-2011 | Feb-2012 | Feb-2024 | May-2024 | Aug-2024 | Nov-2024 | Feb-2025 | May-2025 | Aug-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||||||||||||
| Interest Expense |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Revenue |
27
N/A
|
67
+144%
|
52
-22%
|
71
+37%
|
64
-10%
|
74
+15%
|
83
+12%
|
90
+8%
|
90
+1%
|
83
-8%
|
80
-5%
|
69
-13%
|
57
-18%
|
0
-100%
|
0
+584%
|
0
+17%
|
0
+25%
|
0
-6%
|
0
-12%
|
0
-51%
|
|
| Gross Profit | |||||||||||||||||||||
| Cost of Revenue |
(22)
|
(54)
|
(42)
|
(56)
|
(51)
|
(56)
|
(61)
|
(65)
|
(61)
|
(56)
|
(52)
|
(44)
|
(39)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Gross Profit |
5
N/A
|
13
+149%
|
10
-20%
|
15
+43%
|
13
-10%
|
18
+34%
|
22
+21%
|
24
+13%
|
29
+19%
|
27
-7%
|
27
+0%
|
25
-8%
|
18
-27%
|
0
-100%
|
0
+726%
|
0
+28%
|
0
+25%
|
0
-9%
|
0
-12%
|
0
-59%
|
|
| Operating Income | |||||||||||||||||||||
| Operating Expenses |
(0)
|
(2)
|
(1)
|
(30)
|
(30)
|
(31)
|
(32)
|
(5)
|
(15)
|
(13)
|
(13)
|
(13)
|
(6)
|
(0)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
|
| Selling, General & Administrative |
(0)
|
(2)
|
(1)
|
(30)
|
(30)
|
(31)
|
(32)
|
(5)
|
(15)
|
(12)
|
(13)
|
(14)
|
(6)
|
(0)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
|
| Depreciation & Amortization |
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Operating Income |
5
N/A
|
11
+134%
|
9
-16%
|
(15)
N/A
|
(17)
-12%
|
(13)
+21%
|
(11)
+20%
|
19
N/A
|
14
-24%
|
14
-1%
|
14
0%
|
12
-18%
|
12
+5%
|
(0)
N/A
|
(0)
-204%
|
(0)
+41%
|
(0)
-21%
|
(0)
+9%
|
(0)
-33%
|
(0)
+5%
|
|
| Pre-Tax Income | |||||||||||||||||||||
| Interest Income Expense |
0
|
(0)
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Non-Reccuring Items |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Gain/Loss on Disposition of Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
0
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Other Income |
0
|
0
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
0
|
(0)
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Pre-Tax Income |
5
N/A
|
11
+134%
|
9
-18%
|
(15)
N/A
|
(17)
-9%
|
(13)
+24%
|
(10)
+21%
|
20
N/A
|
15
-25%
|
14
-4%
|
14
+0%
|
12
-17%
|
12
+4%
|
(0)
N/A
|
(1)
-211%
|
(0)
+35%
|
(1)
-19%
|
(0)
+6%
|
(1)
-16%
|
(1)
-1%
|
|
| Net Income | |||||||||||||||||||||
| Tax Provision |
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(1)
|
(1)
|
(3)
|
(4)
|
(5)
|
(5)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Income from Continuing Operations |
5
|
11
|
9
|
(15)
|
(17)
|
(13)
|
(10)
|
19
|
14
|
11
|
10
|
7
|
8
|
(0)
|
(1)
|
(0)
|
(1)
|
(0)
|
(1)
|
(1)
|
|
| Income to Minority Interest |
(0)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Net Income (Common) |
4
N/A
|
10
+134%
|
9
-18%
|
(16)
N/A
|
(17)
-8%
|
(13)
+22%
|
(11)
+15%
|
18
N/A
|
13
-27%
|
10
-20%
|
10
-8%
|
7
-32%
|
7
+7%
|
(0)
N/A
|
(1)
-211%
|
(0)
+35%
|
(1)
-19%
|
(0)
+6%
|
(1)
-16%
|
(1)
-1%
|
|
| EPS (Diluted) |
2.92
N/A
|
7.4
+153%
|
5.62
-24%
|
-2.41
N/A
|
-1.47
+39%
|
-1.66
-13%
|
-0.87
+48%
|
1.39
N/A
|
1.02
-27%
|
0.81
-21%
|
0.74
-9%
|
0.5
-32%
|
0.51
+2%
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
|